Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 1.00 |
| ▸ | ACHE | P22303 | 4/20 | 1.00 |
| ▸ | MGAM | O43451 | 1/20 | 1.00 |
| ▸ | SI | P14410 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 1/20 | 1.00 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.56 |
| ▸ | HPGD | P15428 | 10/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decursinol SCHEMBL14105325 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| Decursinol SCHEMBL3895912 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| Decursinol SCHEMBL29517185 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| Decursinol SCHEMBL18845442 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL14105337 | 0.86 | GAA (0.76) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL23983278 | 0.83 | GAA (0.71) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL14303567 | 0.82 | MAOA (0.79) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL4740846 | 0.82 | MAOA (0.79) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL15444405 | 0.80 | MAOA (0.67) | GAAACHEMGAMSIPTPN1 | |
| Decursin SCHEMBL14511556 | 0.80 | MAOA (1.00) | GAAACHEMGAMSIPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2841109-B1 | PRODRUGS OF HYDROXYL-COMPRISING DRUGS | ASCENDIS PHARMA AS (DK) | 2026-04-15 | — | — | EP | disclosed |
| EP-3617211-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES CONTAINING DECURSIN DERIVATIVE AS ACTIVE INGREDIENT | PRG S&TECH INC (KR) | 2025-10-22 | — | — | EP | disclosed |
| US-12391704-B2 | Method for synthesizing decursin derivative | PRG S&TECH INC. (KR) | 2025-08-19 | — | — | US | disclosed |
| EP-4083045-B1 | NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE | PRG S&TECH INC (KR) | 2023-12-13 | — | — | EP | disclosed |
| US-20230063754-A1 | NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE | PRG S&TECH INC. (KR) | 2023-03-02 | — | — | US | disclosed |
| EP-4083045-A1 | NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE | PRG S&Tech Inc. (KR) | 2022-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12391704-B2 | Method for synthesizing decursin derivative | DHPS, NISCH, DOHH | GAA 4779/4885ACHE 4626/4885MGAM 4471/4885 |
| US-20230063754-A1 | NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE | DHPS, NISCH, NMUR2 | GAA 4752/4885ACHE 4657/4885MGAM 4503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.